ESRX News Alert Express Scripts (ESRX) 85.48 12/25/2014 05:3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Express Scripts (ESRX) 85.48 $ESRX

Biotech Stocks Take A Beating, But Find Support
at Investor's Business Daily - Wed Dec 24, 5:24PM CST
Biotech stocks took a bath in this holiday-shortened week. The catalyst was the announcement by Express Scripts (ESRX), the nation's largest benefits manager, to use AbbVie's (ABBV) hepatitis C drug exclusively. That hurt Gilead Sciences (GILD),...
CBPO: 64.79 (-0.59), ODFL: 79.34 (+0.71), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), AMGN: 160.67 (+3.15), ABBV: 66.21 (+1.86), CELG: 109.60 (+3.48)


US stocks eke out gains in abbreviated trading day
By ALEX VEIGA - AP - Wed Dec 24, 3:23PM CST
Major U.S. stock indexes ended mostly higher on Wednesday, with the Dow Jones industrial average adding modestly to its gains a day after closing above 18,000 for the first time.
ESRX: 85.48 (-0.40), WFC: 55.34 (-0.13), CVX: 113.47 (-0.48), WAG: 76.67 (+0.16)

Could Express Scripts Holding Company's Gilead Gamble Backfire?
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 24, 12:03PM CST
Source: CVS Health. In case you missed it, the hepatitis C community was turned on its head this past weekend with the approval of a new hepatitis C compound and a major move by a pharmacy-benefits manager to strike a long-term deal with that...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), CVS: 97.89 (+0.02), ABBV: 66.21 (+1.86), WAG: 76.67 (+0.16)

First Week Of August 2015 Options Trading For Express Scripts Holding
at The Street - Wed Dec 24, 12:01PM CST
Investors in Express Scripts Holding Co saw new options become available this week, for the August 2015 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until...
ESRX: 85.48 (-0.40)

Stocks Score Small Gains; Virgin America Takes Flight
at Investor's Business Daily - Wed Dec 24, 10:57AM CST
Stocks were filled with Christmas cheer with a little more than one hour remaining in Wednesday's shortened session. The Dow Jones industrial average and the S&P 500 were trading at all-time highs. The Nasdaq led the charge, up 0.4%. The S&P 500 and...
ESRX: 85.48 (-0.40), V: 267.63 (+2.37), VA: 41.00 (+5.19), GILD: 91.29 (+1.84), BAC: 17.98 (+0.05), SN: 9.91 (-0.71), ABBV: 66.21 (+1.86), CELG: 109.60 (+3.48)

What Happened To Gilead Is Health Reform In Action
Dana Blankenhorn - at Seeking Alpha - Wed Dec 24, 10:40AM CST

ESRX: 85.48 (-0.40)

Today's Market: Buying Biotech, Tech And Shipping News
Matthew Smith - at Seeking Alpha - Wed Dec 24, 9:19AM CST

NFLX: 342.10 (+5.67), FDX: 176.42 (-0.52), AMZN: 303.03 (-3.26), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), DTV: 86.82 (-0.05), SNE: 21.32 (+0.46), DIS: 94.42 (-0.27), AAPL: 112.01 (-0.53), UPS: 112.41 (-0.04)

Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers
Peter F. Way, CFA - Seeking Alpha - Wed Dec 24, 8:33AM CST
This is a market price forecast analysis It is not an analysis of medical technology, competition, or economics. We have limited competence in those areas. But we do have extensive experience in how market professionals have interpreted the likely...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), FBT: 100.93 (+1.47), BIB: 122.51 (+3.83), XBI: 182.62 (+3.44), IBB: 299.80 (+5.12), BBH: 113.91 (+1.89), ABBV: 66.21 (+1.86)

Jim Cramer's Picks for What to Buy in Oil and Biotech Into 2015
at The Street - Wed Dec 24, 7:45AM CST
Here's the best way to play oil and biotech.
CI: 104.23 (-0.08), ESRX: 85.48 (-0.40), RDS.A: 68.42 (-0.31), ISIS: 59.49 (+1.88), COG: 30.21 (-0.39), UNH: 102.68 (-0.17), EOG: 94.05 (-2.36), SLB: 87.06 (-0.26), EPD: 35.45 (+0.25), CELG: 109.60 (+3.48)

Why I Expect The Biotech Sell-Off To Continue Into 2015
Sammy Pollack - at Seeking Alpha - Wed Dec 24, 7:08AM CST

BIIB: 340.89 (+5.13), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), IBB: 299.80 (+5.12), AMGN: 160.67 (+3.15), REGN: 400.12 (+6.07), CELG: 109.60 (+3.48)

Gilead Feels The Heat Of Competition
Brendan O'Boyle - at Seeking Alpha - Wed Dec 24, 6:59AM CST

ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86)

Express Scripts Sees Heavy Call Volume as Bulls Clean Up
at The Street - Wed Dec 24, 4:30AM CST
Express Scripts has been a monster, and bullish option traders cleaned up quick Tuesday.
ESRX: 85.48 (-0.40)

Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 3:50PM CST
Pharmacy benefit manager Express Scripts (ESRX) announced an update to its National Preferred Formulary, which will now include AbbVie's (ABBV) recently approved new medication for hepatitis C, Viekira Pak.
JNJ: 104.59 (+0.31), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86), CRL: 63.59 (+0.33)

AbbVie Puts The Hurt On Gilead Sciences, Closes Exclusive Deal With Express Scripts
Kal Telage - at Seeking Alpha - Tue Dec 23, 3:41PM CST

JNJ: 104.59 (+0.31), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86)

Dow Reaches Record Close as Santa Claus Rally Hits Day 5
at The Street - Tue Dec 23, 3:04PM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as third-quarter GDP shows signs of better-than-expected economic health.
PSX: 72.10 (-0.46), HTZ: 24.38 (-0.09), GMCR: 137.65 (+1.10), OCN: 14.88 (-0.14), XOM: 93.78 (-0.81), NQ: 4.32 (-0.36), XLV: 68.64 (+0.50), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), CVX: 113.47 (-0.48), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07), XLE: 80.13 (-0.59)

Why Achillion Pharmaceuticals Shares Collapsed by 25% Today
Todd Campbell, The Motley Fool - Motley Fool - Tue Dec 23, 2:03PM CST
Source: Achillion Pharmaceuticals What's happening? Shares of Achillion Pharmaceuticals are crashing 25% today after the company reported mixed early stage drug trial results yesterday and following Express Scripts ' decision to remove ...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), ABBV: 66.21 (+1.86)

Investors Should Stay Long Stocks as Market Continues Hitting Highs
at The Street - Tue Dec 23, 2:01PM CST
The CNBC 'Fast Money Halftime' trading panel knows there could be some risks in 2015.
AMZN: 303.03 (-3.26), IBB: 299.80 (+5.12), ALSN: 33.94 (+0.05), BAC: 17.98 (+0.05), TLT: 123.95 (+0.41), GOOG: 528.77 (-1.82), ESRX: 85.48 (-0.40), SPY: 207.77 (+0.02), QQQ: 104.30 (+0.09), GILD: 91.29 (+1.84), DIA: 180.03 (unch), APA: 64.05 (-1.38), ABBV: 66.21 (+1.86), BP: 38.95 (-0.17), GOOGL: 536.93 (-1.84), IWM: 119.76 (-0.10), XLE: 80.13 (-0.59)

Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations
at The Street - Tue Dec 23, 1:25PM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as third-quarter GDP shows signs of better-than-expected economic health.
GPRO: 66.41 (+4.87), GMCR: 137.65 (+1.10), OCN: 14.88 (-0.14), NQ: 4.32 (-0.36), XLV: 68.64 (+0.50), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07)

Gilead Sciences Plunges for Second Day In A Row: What Wall Street's Saying
at The Street - Tue Dec 23, 12:48PM CST
The biotech stock's shares fell again Tuesday following the news of Express Scripts' exclusive deal with AbbVie. Here's what analysts said about Gilead.
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86)

Express Scripts (ESRX) On Momo Momentum Watch Today
at The Street - Tue Dec 23, 11:24AM CST
Trade-Ideas LLC identified Express Scripts (ESRX) as a momo momentum candidate
ESRX: 85.48 (-0.40)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 113

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Pinnacol’s Community Work Earns Denver Chamber Recognition

Updated Category News Views 67

A workers’ comp insurer usually becomes visible on somebody’s worst day; Pinnacol Assurance is being recognized for the work it keeps doing around those days. The Denver Metro Chamber of Commerce has given the Colorado-based, member-owned carrier its 2026 Business Impact Award for Corporate Social Responsibility. Awards can be cheap applause, frankly. This one...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 107

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 122

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 100

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
AMD Faces Fresh Scrutiny Over China Supply Exposure

Updated Category News Views 130

One nasty report can turn a chip giant’s supply chain into a flashing red light, and that is precisely the mess confronting Advanced Micro Devices investors this week. Shares fell more than 7.7% on November 19 after Hunterbrook Media published allegations involving China-linked sales, firmware and manufacturing relationships. Then, on November 20, shareholder-rights...

Continue Reading
Payoneer Gets OCC Nod, but the Finish Line Is Ahead

Updated Category News Views 121

Federal bank paperwork is not usually thrilling, yet Payoneer just found a potentially meaningful lever for its cross-border payments machine. The company received preliminary conditional approval from the Office of the Comptroller of the Currency to form PAYO Digital Bank, a national trust bank intended to support stablecoin services. That is a real regulatory milestone...

Continue Reading
ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 108

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading

Top 5 Most Recently Viewed Articles

ICG Enterprise Trust plc Announces Share Repurchase Details

Updated Category News Views 159

ICG Enterprise Trust plc Share Buyback Announcement ICG Enterprise Trust plc (the “Company”) The Company has announced a recent development regarding its share buyback initiative. On a significant date, it repurchased 15,000 of its own shares aimed to be held as treasury shares, with each share valued at an average price of 1450 pence. Details of the Transaction...

Continue Reading
Converge Technology Solutions Shares Third Quarter 2024 Insights

Updated Category News Views 217

Converge Technology Solutions Announces Preliminary Q3 Results Converge Technology Solutions Corp. (CTS) has released its preliminary unaudited financial results for the third quarter of 2024. The company is committed to delivering insightful updates to its stakeholders as part of its transparency approach. The company stated that all figures are presented in Canadian...

Continue Reading
Discovery Silver Corp. Unveils 2023 ESG Report

Updated Category News Views 104

Discovery Silver Corp. Releases 2023 ESG Report Key Highlights: Earned Quality Environmental Certification from the Mexican Government Recognized as a Socially Responsible Enterprise by the Mexican Center for Philanthropy Achieved Great Place to Work Certification Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) is excited to announce the publication of its 2023...

Continue Reading
Final Call for Subscription in IDEX Biometrics Offering Today

Updated Category News Views 152

Important Subscription Period Details for IDEX Biometrics Today marks a significant turning point for IDEX Biometrics ASA as the subscription period for their subsequent offering of shares closes. The company previously announced that they aim to issue up to 600 million new shares at a remarkable subscription price of NOK 0.01 per share. This offering, essential for...

Continue Reading
Dundee Corporation Strengthens Position in Greenheart Gold Inc.

Updated Category News Views 33

Overview of Recent Acquisition Dundee Corporation (TSX: DC.A) has announced that its wholly-owned subsidiary, Dundee Resources Limited, recently acquired 2,000,000 common shares of Greenheart Gold Inc. (TSXV: GHRT) at a price of C$0.50 per share, totaling an investment of C$1,000,000. This acquisition is part of the Issuer's bought deal private placement and signifies...

Continue Reading